Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?
- PMID: 12707450
- DOI: 10.1212/01.wnl.0000055847.17752.e6
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?
Abstract
Patients with mild cognitive impairment (MCI) were assessed, and a metabolic profile associated with conversion to AD at 18-month follow-up was sought. As compared with nonconverters (n = 10), converters (n = 7) had lower fluorodeoxyglucose uptake in the right temporoparietal cortex (p = 0.02, corrected for cluster size), without individual overlap. Awaiting replication in an independent sample, these findings suggest that among patients with MCI, fluorodeoxyglucose PET may accurately identify rapid converters.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials